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The effect on lactose production of several external modulators of intracellular cyclic AMP was studied 
in rat mammary gland tissue slices and explants. Adrenaline, a fi-adrenergic receptor effector, forskolin, 
a direct adenylate cyclase activator and fluphenazine, a calmodulin inhibitor, all produced an increase in 
the intracellular level of cyclic AMP and a concomitant inhibition of lactose production. These results sug- 
gest a role for adrenaline and calmodulin in modulating cyclic AMP levlels in mammary tissue during the 
lactogenic cycle. 
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1. INTRODUCTION 
It is well known that cyclic nucleotides and CaZt 
are key regulatory signals in the normal progress of 
the lactogenic cycle in the rat and other mammals 
[l-3]. Cyclic AMP presents a sustained increase 
during pregnancy reaching a maximum near par- 
turition and a minimum at the beginning of lacta- 
tion. Levels of cyclic GMP, on the other hand, 
show opposite changes. This pattern suggests that 
cyclic AMP is a negative controlling factor for Iac- 
togenesis through phosphorylation of key proteins 
and/or repression mechanisms of those systems in- 
volved in the synthesis and liberation of milk con- 
stituents. The most dramatic and rapid effect of 
cyclic AMP in mammary tissue is the inhibition of 
lactose production, for which several explanations 
have been offered [4]. A unifying element for all of 
them has been the involvement of calmodulin, a 
low-1w; protein which binds Ca2+ and modulates 
several enzyme activities, particularly cyclic 
nucleotide phosphodiesterase which on activation 
lowers the intracellular cyclic AMP concentration. 
Both the activation of the high-Km cyclic AMP 
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phosphodiesterase by calmoduiin and the increase 
in calmodulin during lactation are in accordance 
with the cyclic AMP decrease mentioned for this 
period [X,3]. 
Here, we describe experiments in which we have 
analyzed the effect of adrenaline (a P-adrenergic 
receptor effector), forskolin (an adenylate cyclase 
effector) and fluphen~ine (a calmodulin inhibitor) 
on lactose production in rat mammary gland 
tissue. The results suggest that both adrenaline and 
calmodulin may play an important role in 
modulating cycIic AMP levels during the lac- 
togenic cycle. 
2. MATERIALS AND METHODS 
Sprague-Dawley rats at middle pregnancy and 
lactation were used. The animals were killed by 
decapitation and the abdominal mammary glands 
were prepared directly for determination of en- 
zymes and metabolites or for explant cultures. 
Cyclic [S-3H]AMP and L-~3sS]methionine were 
obtained from New England Nuclear; Duibecco’s 
modified Eagle’s medium (DMEM) from Flow 
Laboratories; ( - )-adrenaline, fl-galactosidase and 
galactose dehydrogen~e from Sigma; and for- 
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skolin from Calbiochem. 2-Chloro-lo-(3-amino- 
propyl)phenothiazine (CAPP), conjugated to 
Sepharose 4B (CAPP-Sepharose) was a gift from 
Dr E. Jedlicky (Dept of Biochemistry, Faculty of 
Medicine, University of Chile). 
eluted with 10 mM Tris-HCI, 5 mM EGTA, pH 
8.0. Calmodulin activity and radioactivity were 
determined in the elution volume. 
3. RESULTS AND DISCUSSION 
2.1. Calrnodulin assay 
The stimulation of activator-deficient cyclic 
AMP phosphodiesterase was determined as 
described in [2]. 
2.2. Cyclic AMP and lactose determinations 
Cyclic AMP was determined by the competitive 
protein binding assay of Tovey et al. [5], and lac- 
tose by the double enzyme method @- 
galactosidase/galactose d hydrogenase) [6]. 
2.3. Adrenaline effect on cyclic AMP and lactose 
production 
This effect was studied in mammary gland ex- 
plants from middle lactation, freed of pre-existent 
lactose [7], and cultured in DMEM. The incuba- 
tion was performed in the presence of increasing 
concentration of ( - )-adrenaline (lo-‘- 10m4 M) in 
0.5 M ascorbic acid. Cyclic AMP levels in explants 
were determined after 10 min incubation; lactose 
determination in explants and media was carried 
out after 120 min incubation. 
2.4. Fluphenazine and forskolin effects in 
lactating mammary gland slices 
Rat mammary gland slices were prepared 
according to Loizzi et al. [4]. The slices were in- 
cubated with shaking in Krebs-Ringer bicarbonate 
solution in the presence and absence (control) of 
200pM fluphenazine or 100pM forskolin. Tissue 
lactose and cyclic AMP were determined at the in- 
dicated times. 
2.5. Calmodulin characterization 
Mammary gland explants were cultured in 
DMEM containing bovine insulin (5 fig/ml), ovine 
prolactin (10 pg/ml) and corticosterone (1 pg/ml) 
[8]. [35S]Methionine (100&i) was added to the 
media for 48 h, then the purification steps de- 
scribed by Charbonneau and Cormier [9] were 
used. A CAPP-Sepharose 4B column, the last step 
of purification, equilibrated with 10 mM Hepes, 
0.5 M CaClz, pH 7.0, was washed with the same 
buffer containing 0.5 M NaCl. Calmodulin was 
Changes in cyclic AMP and lactose concentra- 
tion in response to adrenaline (see section 2) are 
shown in fig. 1. A sizeable increase in cyclic AMP 
in response to increasing concentrations of 
adrenaline was observed together with a concomi- 
tant decrease in lactose, in both the tissue explant 
and incubation medium. 
To determine the effect of calmodulin on lactose 
production we incubated mammary gland slices in 
Krebs-Ringer bicarbonate in the presence and 
absence of 200pM fluphenazine. As shown in 
fig.2, there is a sustained ecrease with time in lac- 
tose concentration in the medium which reached 
35% of the control level 90 min after addition of 
the inhibitor. The decrease in lactose was accom- 
panied by an increase in cyclic AMP concentration 
which reached a maximum during the first minute 
of incubation (fig.2). The presence of calmodulin 
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Fig.1. Effect of (-)-adrenaline on cyclic AMP 
production in explants of lactating mammary gland. (A) 
Tissue explant cyclic AMP; (0) tissue explant lactose; 
(0) lactose in the incubation media. Each value 
represents the mean of 3 determinations with SE not 
exceeding 5% for lactose and 10% for cyclic AMP 
values. 
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Fig.2. Fluphenazine (200 PM) effect on lactose secretion 
(0) and tissue cyclic AMP (a); (e) lactose secretion 
without fluphenazine. Initial cyclic AMP value 7.0 f 
0.5 nmol/g. Each value represents the mean of 3 
different determinations + SE. 
was verified by the reversible calcium-dependent 
binding property of this protein to immobilized 
phenothiazines (CAPP-Sepharose column). As 
shown in fig.3, there is a good correlation between 
the maximal radioactive profile and the maximal 
activation of phosphodiesterase after elution with 
EGTA. Incubation of mammary gland slices with 
forskolin at 100 PM resulted in an increase of 90% 
M 
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Fig.3. CAPP-Sepharose 4B chromatography of 
mammary gland calmodulin. Fractions were assayed for 
radioactivity (0) and calmodulin activity (0) (for details 
see section 2). 
of tissue cyclic AMP and a decrease of 50% of lac- 
tose in the medium after 60 min incubation (not 
shown). 
The inhibitory action of cyclic AMP on lactose 
production is a rapid process in which several fac- 
tors would act as a whole, the inhibition of glucose 
uptake [lo] and the decrease in cu-lactalbumin pro- 
duction being the most direct effects [l 11. On the 
other hand, the biochemical mechanisms which ac- 
count for the decrease in cyclic AMP level, allow- 
ing the onset of lactogenesis, are also multiple; 
amongst these are the hydrolysis by cyclic AMP 
phosphodiesterase and the excretion of cyclic 
AMP through milk as lactation proceeds [4,12]. 
Our results suggest that both adrenaline and 
calmodulin may play an important role in 
modulating cyclic AMP levels during the lac- 
togenic cycle. Adrenaline most likely exerts its ef- 
fect by triggering ,&adrenergic receptors [13] and 
together with other hormones acting through 
adenylate cyclase may be responsible for the rise in 
cyclic AMP. A role for calmodulin is not surpris- 
ing as we recently presented evidence for the ex- 
istence in mammary gland of a protein with similar 
characteristics [ 141. Furthermore, we have shown 
that anticalmodulin in drugs such as 
phenothiazines are efficient inhibitors of the 
stimulatory action of prolactin on RNA and casein 
synthesis in mammary gland explants from virgin 
rats [14]. Taken together, our present results con- 
firm the existence and functionality of calmodulin 
in the gland and support its role in association with 
Ca’+, in differentiation as well as in prolactin ac- 
tion [14,15]. 
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